Erectile Dysfunction: Comprehensive Etiology and Management Framework

Erectile dysfunction (ED) is persistent inability to achieve/maintain erection sufficient for satisfactory sexual activity. Prevalence: ~40% at 40, ~70% at 70. Multifactorial etiology.

Organic (Physical) Causes

  • Vascular (70%): Atherosclerosis (penile arteries 1–2mm → early sentinel for CVD), endothelial dysfunction, venous leak. Risk: HTN, dyslipidemia, diabetes, smoking.
  • Neurogenic: Diabetic neuropathy, spinal cord injury, MS, Parkinson's, pelvic surgery (RP, rectal), radiation.
  • Hormonal: Hypogonadism (low T), hyperprolactinemia, thyroid disorders.
  • Structural: Peyronie's disease (fibrotic plaque), congenital curvature.
  • Medication-Induced: Antidepressants (SSRIs), antihypertensives (thiazides, beta-blockers), 5-ARIs, antiandrogens, opioids.
  • Lifestyle: Obesity, sedentary, alcohol, smoking, cycling (perineal compression).

Psychogenic Causes

  • Performance anxiety, depression, stress, relationship conflict, pornography-related, sexual trauma, body image.
  • Often sudden onset, situational, preserved nocturnal erections.

Diagnostic Approach

  1. History (IIEF-5/15), medication review, psychosocial screen.
  2. Focused exam: genital, vascular (pulses), neurologic, secondary sexual characteristics.
  3. Labs: Glucose/HbA1c, lipid panel, total/free testosterone (AM), LH, prolactin, TSH.
  4. Specialized: Nocturnal penile tumescence (RigiScan), penile Doppler ultrasound, dynamic infusion cavernosometry.

Treatment Algorithm

  1. Lifestyle modification (weight loss, exercise, smoking cessation, Mediterranean diet).
  2. Oral PDE5 inhibitors (sildenafil, tadalafil, vardenafil) — first-line pharmacotherapy.
  3. Vacuum erection device.
  4. Intracavernosal injections (alprostadil, bimix, trimix).
  5. Intraurethral alprostadil (MUSE).
  6. Penile prosthesis (inflatable/malleable) — definitive for refractory.
  7. Psychosexual therapy (CBT, sensate focus) for psychogenic/mixed.
  8. Testosterone replacement if hypogonadal (with monitoring).

ED is a window to cardiovascular health; new-onset ED warrants CVD risk assessment.

Urinary Disorders - Related Articles